# A Trial to Evaluate Efficacy of Heart-protecting Musk Pill

Study · id `cardio:ct-nct01897805` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01897805](<https://clinicaltrials.gov/study/NCT01897805>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01897805

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 2700 participants.

## Technical summary

Registry record NCT01897805. Randomized; quadruple masking; primary purpose treatment. Start 2011-07 (registry gives no type); primary completion 2015-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 2700 participants (planned count; ClinicalTrials.gov record NCT01897805, source copy `cardio:ctgov-nct01897805-2014-12-19`, retrieved 2026-10-26)
- Start date: 2011-07 (registry gives no type) (ClinicalTrials.gov record NCT01897805, source copy `cardio:ctgov-nct01897805-2014-12-19`, retrieved 2026-10-26)
- Primary completion: 2015-06 (anticipated) (ClinicalTrials.gov record NCT01897805, source copy `cardio:ctgov-nct01897805-2014-12-19`, retrieved 2026-10-26)
- Completion: 2015-12 (anticipated) (ClinicalTrials.gov record NCT01897805, source copy `cardio:ctgov-nct01897805-2014-12-19`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT01897805, source copy `cardio:ctgov-nct01897805-2014-12-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01897805-2014-12-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Trial to Evaluate Efficacy of Heart-protecting Musk Pill
- Condition: Coronary Artery Disease
- Intervention (Drug): Heart-protecting Musk Pill
- Intervention (Drug): Placebo
- Lead sponsor: Shanghai Hutchison Pharmaceuticals Limited
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Shanghai Hutchison Pharmaceuticals Limited (`cardio:org-shanghai-hutchison-pharmaceuticals-limited`)

## Provenance

Content hash: 83d770fd49c86b837d297ff3e61314e908f6bf4b41b84a26ac64cf81d474fa32
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
